A Study of IBI311 in Subjects With Steroid-resistant, Thyroid Associated Ophthalmopathy

NCT06269393 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Thyroid Associated Ophthalmopathy

Interventions

DRUG: Placebo
DRUG: IBI311

Sponsor

Peking University People's Hospital